ARTICLE
Auteur(s) : Chen-Ming Xu1,2, Xiao-Ling
Chen2, Chun-Yue Chen2, Xian-Ning
Zhang2
1Department of Reproductive Endocrinology,
Women’s Hospital, Zhejiang University School of Medicine,
Hangzhou, China
2Institute of Cell Biology and Department
of Biochemistry & Genetics, National Education Base
for Basic Medical Sciences, Zhejiang University School
of Medicine, Hangzhou, China
Epidermolytic palmoplantar keratoderma (EPPK, OMIM: 144200) is
an autosomal dominant (AD) genodermatosis characterized by diffuse
hyperkeratosis confined to the palmar and plantar epidermis.
Keratin 9 (K9) is expressed in a very specific manner limited to
palms and soles, making this a prime candidate for EPPK [1, 2].
There are 18 different mutations reported in the 1A domain and 2
mutations in the 2B domain of K9 (Human Intermediate Filament
Mutation Database, www.interfil.org).
We present both a kindred and a sporadic case from Fujian and
Guangdong province of southern China, respectively, diagnosed with
EPPK, based on the clinical and histological examinations. The same
KRT9 missense mutation (p.R163W) in the 1A domain was confirmed.
This is the first report of a p.R163W mutation of EPPK on the
Chinese mainland.
The pedigree is a four-generation family including 9 affected
and 22 unaffected individuals, exhibiting AD inheritance (figure 1A). All the
affected family members showed severe epidermolytic hyperkeratosis,
surrounded by a characteristic erythematous border on the
palmoplantar surface. No other body sites were involved. The
isolated case is a 9-year-old girl without any siblings, her growth
and development have been normal to date. Her parents described the
presentation of erythema and peeling of skin confined to the palms
and soles soon after birth, with progressive symmetric
hyperkeratosis which appeared 3-4 months later (figure 1B). The severity
of the skin lesions runs in cycles of improvement and worsening
with seasonal variations. After obtaining informed consent, 21
blood samples from the four-generation family (7 affected and 14
unaffected individuals) and 5 samples from the sporadic case were
collected. Molecular genetic analysis, including polymerase chain
reaction (PCR), denaturing high-performance liquid chromatography
(DHPLC) and DNA sequencing for the 7 encoding exons of KRT9 was
undertaken, guided by our previous work on Chinese EPPK [2].
After a 436-bp fragment of exon 1 encoding part of the head
domain and helix 1A of K9 was amplified from affected and
unaffected individuals and subjected to hetero-duplex analysis
using DHPLC, different profiles were observed (figure 1C). The normal
profile exhibited a single peak, while profiles of all affected
members showed four distinct peaks, which were observed under
partial denaturing conditions (at 59.8°C). This indicated a
sequence variation within the fragment analyzed. Sequence analysis
identified a C-to-T transition at nucleotide 487 that resulted in
an arginine (CGG) to tryptophan (TGG) substitution at position 163
in all affected individuals, as compared with the normal sequence
(figure 1C).
There was also a homozygous single nucleotide polymorphism (c.
429A>C transversion) in all affected and unaffected members,
which did not result in amino acid changes (data not shown)
[3].
The majority of keratin mutations are usually in the helix
initiation (1A) or termination (2B) motifs [4]. Mutations in the
boundary peptides are highly disruptive to filament assembly, cause
tonofilament aggregation, and generally lead to more severe
phenotypes. In the case of K9, the 1A hotspot mutations are p.R163W
and p.R163Q which arise commonly because of a CpG methylation site
within this codon, leading to chemical instability [3, 5]. It is
believed the major form of DNA modification in the human genome
involves methylation of cytosine residues (to form
5-methylcytosine), specifically when they are located immediately
5’ to a guanine (i.e., as the dinucleotide 5’-CG-3’). Spontaneous
deamination of 5-methylcytosine to thymidine in the CG doublet
gives rise to C>T or G>A transitions (depending on the strand
of DNA in which the 5-methylcytosine is mutated). More than 30% of
all single nucleotide substitutions are of this type, and they
occur at a rate 25 times greater than any other random mutation
occurs [5]. Thus, the CG doublet represents a true “hotspot” for
mutation, especially for spontaneous, de novo mutation in human
genetic disease genes. Here, substitution of arginine by virtually
any other amino acid (with the sole possible exception of lysine)
will prevent the formation of H-bonds which are required to
stabilize the coiled-coil, resulting in loss of 1A stability. Our
report of a spontaneous p.R163W mutation in a southern Chinese
patient, together with the previous reports in Taiwan provide
supporting evidence for the hypothesis that codon 163 of KRT9 is
fatal for keratin filament assembly and an important hotspot for
mutation in EPPK, regardless of race or ethnicity [3, 6].
Acknowledgements
This work was supported by the National Nature Science Foundation
of China (No. 30672250). Conflict of interest: none.
References
1 Terrinoni A, Cocuroccia B, Girolomoni G,
et al. Identification of the keratin K9 R162W mutation in
patients of Italian origin with epidermolytic palmoplantar
keratoderma. Eur J Dermatol 2004; 14: 375-8.
2 Zhang XN, He XH, Lai Z, et al. An
insertion-deletion mutation in keratin 9 in three Chinese families
with epidermolytic palmoplantar keratoderma. Br J Dermatol 2005;
152: 804-6.
3 Chiu HC, Jee SH, Sheen YS, et al. Mutation
of keratin 9 (R163W) in a family with epidermolytic palmoplantar
keratoderma and knuckle pads. J Dermatol Sci 2007; 45: 63-5.
4 Feng W, Han W, Man X, et al.
Identification of the keratin 9 (KRT9) N161S mutation in a Chinese
kindred with epidermolytic palmoplantar keratoderma. Eur J Dermatol
2008; 18: 387-90.
5 Walsh CP, Xu GL. Cytosine methylation and DNA
repair. Curr Top Microbiol Immunol 2006; 301: 283-315.
6 Yang MH, Lee JY, Lin JH, Chao SC. De novo
mutation of keratin 9 gene in two Taiwanese patients with
epidermolytic palmoplantar keratoderma. J Formos Med Assoc 2003;
102: 492-6.
|